INVO BIOSCIENCE INC. IVOB news, videos and press releases
For more news please use our advanced search feature.
INVO BIOSCIENCE INC. IVOB - More news...
INVO BIOSCIENCE INC. IVOB - More news...
- NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal
- NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
- INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
- INVO Reports Record Third Quarter 2023 Financial Results
- NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
- INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
- INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
- INVO Reports Second Quarter 2023 Financial Results
- INVO Closes Acquisition of Wisconsin Fertility Institute
- INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
- INVO Bioscience Announces Closing of $4.5 Million Public Offering
- INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value
- INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023
- INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
- INVO Reports First Quarter 2023 Financial Results
- INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
- INVO Reports Fourth Quarter and Full Year 2022 Financial Results
- INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
- INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek
- INVO Provides Preliminary Update on FY2022 Financial Results
- INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
- INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute
- INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center
- First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology
- INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
- INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
- Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly
- INVO Bioscience Reports Second Quarter 2022 Financial Results
- INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment
- INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China